Polski Holding Farmaceutyczny was founded in 2004 as a capital group consisting of the leading pharmaceutical producers: Polfa Pabianice S.A., Polfa Tarchomin S.A. and Polfa Warszawa S.A. With our patients in mind, we combine experience with the latest technology and invest in research and development to guarantee the effectiveness and safety of our treatment.

Polski Holding Farmaceutyczny SA

REGON (National Register of Business Entities Number): 473243302 NIP (Tax Identification Number):731 188 42 00 KRS (National Court Register): 0000211909
District Court for the Capital City of Warsaw in Warsaw, 12th Economic Division of the National Court Register,
initial capital 579 242 380,00 PLN.

Management Board of Polski Holding Farmaceutyczny S.A.:
Pursuant to the resolution of the Supervisory Board of Polski Holding Farmaceutyczny S.A. No. 212/II/2008 dated 25th February 2008 concerning nomination of the President of the Management Board of Polski Holding Farmaceutyczny S.A., this position has been held since 1st March 2008 by:

• Artur Woźniak - President of the Management Board. Pursuant to the resolution of the Supervisory Board of Polski Holding Farmaceutyczny S.A. No. 198/II/2008 dated 17th January 2008 concerning the specification of the quantitative composition of the Management Board, the Management Board is one-person board.

Supervisory Board:
The following persons are members of the Supervisory Board of Polski Holding Farmaceutyczny S.A.:

• Krzysztof Maślankowski - Chairperson of the Supervisory Board

• Elżbieta Sarnecka - Secretary

• Agnieszka Borek
• Oskar Chejde
• Grzegorz Kędziora
• Mirosław Miara

• Aleksandra Wrochna